File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Pacific Eclipse – A tabletop exercise on smallpox pandemic response

TitlePacific Eclipse – A tabletop exercise on smallpox pandemic response
Authors
Issue Date2022
Citation
Vaccine, 2022, v. 40 n. 17, p. 2478-2483 How to Cite?
AbstractBackground: In December 2019, we ran Pacific Eclipse, a pandemic tabletop exercise using smallpox originating in Fiji as a case study. Pacific Eclipse brought together international stakeholders from health, defence, law enforcement, emergency management and a range of other organisations. Aim: To review potential gaps in preparedness and identify modifiable factors which could prevent a pandemic or mitigate the impact of a pandemic. Methods: Pacific Eclipse was held on December 9–10 in Washington DC, Phoenix and Honolulu simultaneously. The scenario began in Fiji and becomes a pandemic. Mathematical modelling of smallpox transmission was used to simulate the epidemic under different conditions and to test the effect of interventions. Live polling, using Poll Everywhere software that participants downloaded onto their smart phones, was used to gather participant decisions as the scenario unfolded. Stakeholders from state and federal government and non-government organisations from The United States, The United Kingdom, Australia, New Zealand, Canada, as well as industry and non-government organisations attended. Results: The scenario progressed in three phases and participants were able to make decisions during each phase using live polling. The polling showed very diverse and sometimes conflicting decision making. Factors influential to pandemic severity were identified and categorised as modifiable or unmodifiable. A series of recommendations were made on the modifiable determinants of pandemic severity and how these can be incorporated into pandemic planning. These included preventing an attack through intelligence, law enforcement and legislation, improved speed of diagnosis, speed and completeness of case finding and case isolation, speed and security of vaccination response (including stockpiling), speed and completeness of contact tracing, protecting critical infrastructure and business continuity, non-pharmaceutical interventions (social distancing, PPE, border control) and protecting first responders. Discussion: Pacific Eclipse illustrated the impact of a pandemic of smallpox under different response scenarios, which were validated to some extent by the COVID-19 pandemic. The framework developed from the scenario draws out modifiable determinants of pandemic severity which can inform pandemic planning for the ongoing COVID-19 pandemic and for future pandemics.
Persistent Identifierhttp://hdl.handle.net/10722/313937
ISSN
2023 Impact Factor: 4.5
2023 SCImago Journal Rankings: 1.342
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorMacIntyre, CR-
dc.contributor.authorHeslop, DJ-
dc.contributor.authorNguyen, P-
dc.contributor.authorAdam, DC-
dc.contributor.authorTrent, M-
dc.contributor.authorGerber, BJ-
dc.date.accessioned2022-07-05T05:08:33Z-
dc.date.available2022-07-05T05:08:33Z-
dc.date.issued2022-
dc.identifier.citationVaccine, 2022, v. 40 n. 17, p. 2478-2483-
dc.identifier.issn0264-410X-
dc.identifier.urihttp://hdl.handle.net/10722/313937-
dc.description.abstractBackground: In December 2019, we ran Pacific Eclipse, a pandemic tabletop exercise using smallpox originating in Fiji as a case study. Pacific Eclipse brought together international stakeholders from health, defence, law enforcement, emergency management and a range of other organisations. Aim: To review potential gaps in preparedness and identify modifiable factors which could prevent a pandemic or mitigate the impact of a pandemic. Methods: Pacific Eclipse was held on December 9–10 in Washington DC, Phoenix and Honolulu simultaneously. The scenario began in Fiji and becomes a pandemic. Mathematical modelling of smallpox transmission was used to simulate the epidemic under different conditions and to test the effect of interventions. Live polling, using Poll Everywhere software that participants downloaded onto their smart phones, was used to gather participant decisions as the scenario unfolded. Stakeholders from state and federal government and non-government organisations from The United States, The United Kingdom, Australia, New Zealand, Canada, as well as industry and non-government organisations attended. Results: The scenario progressed in three phases and participants were able to make decisions during each phase using live polling. The polling showed very diverse and sometimes conflicting decision making. Factors influential to pandemic severity were identified and categorised as modifiable or unmodifiable. A series of recommendations were made on the modifiable determinants of pandemic severity and how these can be incorporated into pandemic planning. These included preventing an attack through intelligence, law enforcement and legislation, improved speed of diagnosis, speed and completeness of case finding and case isolation, speed and security of vaccination response (including stockpiling), speed and completeness of contact tracing, protecting critical infrastructure and business continuity, non-pharmaceutical interventions (social distancing, PPE, border control) and protecting first responders. Discussion: Pacific Eclipse illustrated the impact of a pandemic of smallpox under different response scenarios, which were validated to some extent by the COVID-19 pandemic. The framework developed from the scenario draws out modifiable determinants of pandemic severity which can inform pandemic planning for the ongoing COVID-19 pandemic and for future pandemics.-
dc.languageeng-
dc.relation.ispartofVaccine-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titlePacific Eclipse – A tabletop exercise on smallpox pandemic response-
dc.typeArticle-
dc.identifier.emailAdam, DC: dcadam@hku.hk-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1016/j.vaccine.2021.10.081-
dc.identifier.pmid34865873-
dc.identifier.scopuseid_2-s2.0-85120794845-
dc.identifier.hkuros333952-
dc.identifier.hkuros334177-
dc.identifier.volume40-
dc.identifier.issue17-
dc.identifier.spage2478-
dc.identifier.epage2483-
dc.identifier.isiWOS:000792898300004-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats